Overview

Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection

Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to see the outcome of Sugammadex versus Neostigmine with Glycopyrrolate in colorectal surgery as it relates to its effects on post-surgical time (in hours) to first bowel movement and tolerance for solid food (GI-2 recovery) following bowel resection surgery
Phase:
Phase 4
Details
Lead Sponsor:
University of California, Irvine
Collaborator:
Merck Sharp & Dohme LLC
Treatments:
Glycopyrrolate
Neostigmine